Publications
Publications
  • April 1989 (Revised January 1994)
  • Case
  • HBS Case Collection

Novo Industri

By: Michael E. Porter and Michael J. Enright
  • Format:Print
  • | Language:English
  • | Pages:20
ShareBar

Abstract

Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an early case in global strategy. The class can understand how Novo has competed internationally in the past, how that relates to industry structure, and how industry changes will alter the appropriate way of competing globally. Coalitions of alliances factor into the list of strategic alternatives.

Keywords

Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry

Citation

Porter, Michael E., and Michael J. Enright. "Novo Industri." Harvard Business School Case 389-148, April 1989. (Revised January 1994.)

About The Author

Michael E. Porter

Strategy
More Publications

More from the Authors